查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403436

到 2030 年经皮贴片市场预测：按成分、应用、配销通路和地区进行的全球分析

Transdermal Skin Patches Market Forecasts to 2030 - Global Analysis By Component, By Application, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球经皮皮肤贴片市场规模为 82 亿美元，预计在预测期内将以 6.6% 的复合年增长率增长，到 2030 年达到 128 亿美元。

经皮皮肤贴片是一种医疗设备，旨在将药物透过皮肤输送到血液中。该贴片由黏合剂、药物储存库和控制膜等层组成，可提供受控和连续的药物释放。该贴片黏合在皮肤上，使药物绕过消化系统直接被吸收到消化器官系统中。它为多种药物提供了一种方便、非侵入性的递送方法，并随着时间的推移保持稳定的治疗水平。

根据 GLOBOCAN 2020 报告，2020 年墨西哥报告了 195,499 例癌症病例，其中乳腺癌和前列腺癌是人群中最常见的癌症。

生长促进因素：与口服药物相比，益处增加

人们越来越偏好经皮吸收贴片，因为它们比口服药物具有明显的优势。这些贴片提供非侵入性药物输送，绕过消化器官系统并减少胃肠道副作用。确保药物的稳定和受控释放，保持一致的治疗水准并提高患者的依从性。它非常方便，特别是对于长期治疗，因为它需要较少的给药次数并且易于给药。此外，经皮吸收贴片缓解了与药物在胃肠道降解相关的问题，提高了生物利用度，并为传统口服药物提供了一种有前途的替代品。

成长抑制因素：认知度低和产品成本上升

对经皮皮肤贴片缺乏认识和产品成本高是主要障碍。消费者和医疗保健专业人员对经皮吸收贴片的好处和用途了解不足可能会限制其采用。此外，配製和製造贴片的製造成本急剧上升，导致市场价格上涨，影响了一些患者的可及性。这些复杂的因素阻碍了广泛的接受度和可负担性，阻碍了这种有效的药物传递系统在多种疾病状态下的潜在用途。

机会：对处方经皮吸收贴片的需求不断增长

对处方经皮吸收贴片不断增长的需求为经皮皮肤贴片市场创造了巨大的机会。这种激增反映了人们对非口服给药方法的偏好不断变化以及对患者便利性的日益重视。随着个人化医疗和标靶治疗的转变，对专门处方笺贴片的需求日益增长。它还正在推动研究改进贴片技术、扩大治疗选择并推动经皮药物领域的市场成长。

威胁：皮肤吸收各种活性物质的能力受到限制

选择性皮肤渗透性是经皮贴片面临的挑战。这种限制限制了适合经皮给药的药物范围，并阻碍了特定治疗方法的开发。此外，大分子、亲水性化合物和具有特定化学性质的化合物难以有效穿过皮肤屏障，限制了适合经皮给药的物质范围。

COVID-19 的影响

COVID-19的爆发对经皮皮肤贴片市场产生了重大影响。对止痛药和荷尔蒙疗法等某些贴片的需求仍然强劲，但供应链和医疗保健的中断影响了生产和分销。封锁也影响了患者就诊，可能导致贴片使用者无法获得新处方或定期检查。然而，这场大流行凸显了非侵入性给药方法的重要性，并可能鼓励未来经皮吸收贴片的进一步创新和广泛普及。

预计在预测期内，黏合药物领域将成为最大的领域

由于其主导地位，黏剂填充药物领域预计将在预测期内主导市场。黏性药物贴片将药物直接融入黏胶层中，确保精确给药并改善皮肤接触。这种设计提供了方便、易于使用和稳定的药物传输。此外，意外分层的风险也被降至最低。由于用户友好的应用和可靠的药物释放曲线，药物贴片预计将在未来仍然是首选，从而增加其在市场上的占有率。

医院药房业务预计在预测期内复合年增长率最高

由于多种因素，医院药房业务预计将显着增长。医院在病患照护中发挥着至关重要的作用，也是药物（包括经皮贴片）的主要分销中心。需要长期用药的慢性病的盛行率不断上升，以及经皮给药系统的采用率不断上升，正在推动对医院药房的需求。此外，医院内补丁的可用性和给药的便利性也有助于市场的预期显着成长。

比最大的地区

由于先进的医疗基础设施、高昂的医疗成本以及对经皮传输系统技术进步的浓厚兴趣，预计北美将引领透皮皮肤贴片市场。此外，患有慢性病的老年人口不断增加以及文明病的流行正在推动对经皮吸收贴片的需求。此外，支持性的法律规范和主要市场参与者的强大影响力也有助于北美的优势。

复合年增长率最高的地区

由于人口不断增加、医疗保健意识不断增强以及慢性病患病率不断上升，预计亚太地区经皮贴剂配方市场将出现显着增长。此外，医疗保健基础设施的改善、向非侵入性治疗的转变以及推动医疗保健进步的新兴国家的出现也为亚太地区的显着增长做出了贡献。此外，积极的政府措施和对改善医疗保健机会的关注也支持了该地区的市场扩张。

免费客製化服务

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 公司之间的竞争关係

第五章全球经皮皮肤贴片市场：依成分分类

  • 水库
  • 含黏合剂药物
    • 单层
    • 多层
  • 矩阵
  • 微型针
  • 其他成分

第六章全球经皮皮肤贴片市场：依应用分类

  • 疼痛管理
  • 心血管疾病
  • 中枢神经系统疾病
  • 荷尔蒙治疗
  • 神经系统疾病
  • 尼古丁戒烟
  • 膀胱过动症
  • 其他用途

第七章全球经皮皮肤贴片市场：按配销通路

  • 医院药房
  • 网路药房
  • 零售药房

第八章全球经皮皮肤贴片市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • 4P Therapeutics
  • AdhexPharma
  • Aveva Drug Delivery Systems
  • Bayer AG
  • Corium, LLC
  • GlaxoSmithKline（GSK）
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Luye Pharma Group
  • Mundipharma
  • Mylan NV
  • Nitto Denko Corporation
  • Novartis
  • Pfizer Inc.
  • Praj HiPurity Systems Limited
  • ProSolus Pharmaceuticals
  • Sorrento Therapeutics Inc
  • Teva Pharmaceuticals
  • TheraDep Technologies
  • Transdermal Delivery Solutions Corporation
Product Code: SMRC24661

According to Stratistics MRC, the Global Transdermal Skin Patches Market is accounted for $8.2 billion in 2023 and is expected to reach $12.8 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Transdermal skin patches are medical devices designed to deliver medication through the skin and into the bloodstream. Comprising layers including an adhesive, drug reservoir and a controlling membrane, these patches offer controlled, continuous drug release. They adhere to the skin, allowing drugs to be absorbed directly into circulation, bypassing the digestive system. They provide a convenient, non-invasive delivery method for various medications, maintaining steady therapeutic levels over time.

According to the GLOBOCAN 2020 report, 195,499 cancer cases were reported in Mexico in 2020, with breast and prostate cancers being the most common among the population.

Market Dynamics:

Driver:

Increasing advantages over the oral and ingesting medications

The rising preference for transdermal skin patches is fueled by their distinct advantages over oral medication. These patches offer non-invasive drug delivery, bypassing the digestive system and reducing gastrointestinal side effects. They ensure a steady, controlled release of medication, maintain consistent therapeutic levels and enhance patient compliance. With fewer dosing frequencies and simplified application, they provide convenience, especially for long-term therapies. Additionally, transdermal patches mitigate issues related to drug degradation in the digestive tract, improving bioavailability and offering a promising alternative to traditional oral medications.

Restraint:

Lack of awareness and elevated product costs

The limited awareness surrounding transdermal skin patches and their higher product costs pose significant restraints. Insufficient knowledge among consumers and healthcare professionals about their benefits and applications may limit their adoption. Moreover, elevated production expenses involved in formulating and manufacturing these patches contribute to higher market prices, impacting accessibility for some patients. These combined factors hinder widespread acceptance and affordability, impeding the potential utilization of this effective drug delivery system for various medical conditions.

Opportunity:

Growing need for prescription transdermal patches

The increasing demand for prescription transdermal patches presents a significant opportunity in the transdermal skin patch market. This surge reflects evolving preferences for non-oral drug delivery methods and a growing emphasis on patient convenience. With a shift toward personalized medicine and targeted therapies, the need for specialized, prescription-based patches is rising. It also fuels research into enhanced patch technologies, expanding treatment options and driving market growth in the transdermal medication sector.

Threat:

Skin's limited capacity to absorb various active substances 

The skin's selective permeability poses a challenge for transdermal patches, as not all substances can effectively penetrate its barriers. This limitation restricts the range of medications suitable for transdermal delivery, hindering the development of certain therapies. Additionally, large molecules, hydrophilic compounds and those with specific chemical properties struggle to traverse the skin barrier effectively, limiting the range of substances suitable for transdermal delivery.

COVID-19 Impact:

The COVID-19 pandemic has significantly influenced the transdermal skin patches market. While demand for certain patches, like those delivering pain relief or hormone therapies, remained steady, disruptions in supply chains and healthcare access impacted production and distribution. Lockdowns also affected patient consultations, potentially hindering new prescriptions and routine check-ups for patch users. However, the pandemic underscored the significance of non-invasive drug delivery methods, potentially driving further innovation and adoption of transdermal patches in the future.

The drug-in-adhesive segment is expected to be the largest during the forecast period

The drug-in-adhesive segment is expected to dominate the market during the forecast period due to its advantages. Drug-in-adhesive patches integrate the drug directly into the adhesive layer, ensuring precise dosing and enhanced skin contact. This design offers convenience, simplicity in application, and consistent drug delivery. Moreover, it minimizes the risk of accidental detachment. With its user-friendly application and reliable drug release profile, the drug-in-adhesive patch is anticipated to remain the preferred choice, fostering its prominence in the market.

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period

The hospital pharmacies segment is poised for significant growth due to various factors. Hospitals play a pivotal role in patient care and are key distribution points for pharmaceuticals, including transdermal patches. The increasing prevalence of chronic diseases requiring long-term medication, coupled with the rising adoption of transdermal drug delivery systems, is driving demand in hospital pharmacies. Additionally, the convenience of obtaining and administering patches within a hospital setting contributes to the projected substantial growth of the market.

Region with largest share:

North America is anticipated to lead the transdermal skin patches market due to its advanced healthcare infrastructure, high healthcare expenditure and robust focus on technological advancements in drug delivery systems. Additionally, a growing elderly population with chronic conditions, coupled with the prevalence of lifestyle-related diseases, fuels the demand for transdermal patches. Moreover, supportive regulatory frameworks and a strong presence of key market players contribute to North America's anticipated dominance.

Region with highest CAGR:

Asia Pacific is poised for notable growth in the transdermal skin patches market owing to the region's expanding population, rising healthcare awareness and increasing prevalence of chronic diseases. Moreover, improving healthcare infrastructure, a shift towards non-invasive treatments, and the presence of emerging economies fostering healthcare advancements contribute to the projected substantial growth in Asia Pacific. Additionally, supportive government initiatives and a focus on enhancing healthcare accessibility further propel market expansion in this region.

Key players in the market:

Some of the key players in transdermal skin patches market include 4P Therapeutics, AdhexPharma, Aveva Drug Delivery Systems, Bayer AG, Corium, LLC, GlaxoSmithKline (GSK), Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Luye Pharma Group, Mundipharma, Mylan N.V., Nitto Denko Corporation, Novartis, Pfizer Inc., Praj HiPurity Systems Limited, ProSolus Pharmaceuticals, Sorrento Therapeutics Inc, Teva Pharmaceuticals, TheraDep Technologies and Transdermal Delivery Solutions Corporation.

Key Developments:

In April 2023, researchers at MIT University developed a wearable patch that enables painless skin patch delivery. The patch utilizes painless ultrasonic waves to create tiny channels, allowing drugs to pass through the tough outer layer of the skin. This innovative approach holds the potential for delivering treatments for various skin conditions. This patch can also be adapted for delivering muscle relaxants, hormones, and other drugs.

In September 2022, Corium launched its Adlarity (donepezil transdermal system) for prescription use in the US Adlarity, a once-weekly patch, delivers consistent doses of donepezil through the skin. It could treat patients with mild, moderate, or severe dementia of Alzheimer's type.

In April 2022, Luye Pharma Group announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) had accepted the Marketing Authorization Application (MAA) for the company's investigational Rivastigmine Twice Weekly Transdermal Patch that was indicated for treating Alzheimer's disease of mild to moderate symptoms.

Components Covered:

  • Reservoir
  • Drug-in-Adhesive
  • Matrix
  • Microneedle
  • Other Components

Applications Covered:

  • Pain Management
  • Cardiovascular Disorders
  • Central Nervous System Disorders
  • Hormonal Therapy
  • Neurological Disorders
  • Nicotine Cessation
  • Overactive Bladder
  • Other Applications

Distribution Channels Covered:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transdermal Skin Patches Market, By Component

  • 5.1 Introduction
  • 5.2 Reservoir
  • 5.3 Drug-in-Adhesive
    • 5.3.1 Single Layer
    • 5.3.2 Multilayer
  • 5.4 Matrix
  • 5.5 Microneedle
  • 5.6 Other Components

6 Global Transdermal Skin Patches Market, By Application

  • 6.1 Introduction
  • 6.2 Pain Management
  • 6.3 Cardiovascular Disorders
  • 6.4 Central Nervous System Disorders
  • 6.5 Hormonal Therapy
  • 6.6 Neurological Disorders
  • 6.7 Nicotine Cessation
  • 6.8 Overactive Bladder
  • 6.9 Other Applications

7 Global Transdermal Skin Patches Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Online Pharmacies
  • 7.4 Retail Pharmacies

8 Global Transdermal Skin Patches Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 4P Therapeutics
  • 10.2 AdhexPharma
  • 10.3 Aveva Drug Delivery Systems
  • 10.4 Bayer AG
  • 10.5 Corium, LLC
  • 10.6 GlaxoSmithKline (GSK)
  • 10.7 Hisamitsu Pharmaceutical Co., Inc.
  • 10.8 Johnson & Johnson
  • 10.9 Luye Pharma Group
  • 10.10 Mundipharma
  • 10.11 Mylan N.V.
  • 10.12 Nitto Denko Corporation
  • 10.13 Novartis
  • 10.14 Pfizer Inc.
  • 10.15 Praj HiPurity Systems Limited
  • 10.16 ProSolus Pharmaceuticals
  • 10.17 Sorrento Therapeutics Inc
  • 10.18 Teva Pharmaceuticals
  • 10.19 TheraDep Technologies
  • 10.20 Transdermal Delivery Solutions Corporation

List of Tables

  • Table 1 Global Transdermal Skin Patches Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 3 Global Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 4 Global Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 5 Global Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 6 Global Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 7 Global Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 8 Global Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 9 Global Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 10 Global Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 11 Global Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 12 Global Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 13 Global Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 14 Global Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 15 Global Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 16 Global Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 17 Global Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 18 Global Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 19 Global Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 20 Global Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 21 Global Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 22 Global Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 23 North America Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 25 North America Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 26 North America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 27 North America Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 28 North America Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 29 North America Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 30 North America Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 31 North America Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 32 North America Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 33 North America Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 34 North America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 35 North America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 36 North America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 37 North America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 38 North America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 39 North America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 40 North America Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 North America Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 42 North America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 43 North America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 44 North America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 45 Europe Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 47 Europe Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 48 Europe Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 49 Europe Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 50 Europe Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 51 Europe Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 52 Europe Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 53 Europe Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 54 Europe Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 55 Europe Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 56 Europe Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 57 Europe Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 58 Europe Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 59 Europe Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 60 Europe Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 61 Europe Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 62 Europe Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 63 Europe Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 64 Europe Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 65 Europe Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 66 Europe Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 67 Asia Pacific Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 69 Asia Pacific Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 70 Asia Pacific Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 71 Asia Pacific Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 72 Asia Pacific Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 73 Asia Pacific Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 74 Asia Pacific Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 75 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 76 Asia Pacific Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 77 Asia Pacific Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 78 Asia Pacific Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 79 Asia Pacific Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 80 Asia Pacific Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 81 Asia Pacific Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 82 Asia Pacific Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 83 Asia Pacific Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 84 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 85 Asia Pacific Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 86 Asia Pacific Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 87 Asia Pacific Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 88 Asia Pacific Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 89 South America Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 91 South America Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 92 South America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 93 South America Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 94 South America Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 95 South America Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 96 South America Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 97 South America Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 98 South America Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 99 South America Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 100 South America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 101 South America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 102 South America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 103 South America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 104 South America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 105 South America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 106 South America Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 107 South America Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 108 South America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 109 South America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 110 South America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 111 Middle East & Africa Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 113 Middle East & Africa Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 114 Middle East & Africa Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 115 Middle East & Africa Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 116 Middle East & Africa Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 117 Middle East & Africa Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 118 Middle East & Africa Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 119 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 120 Middle East & Africa Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 121 Middle East & Africa Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 122 Middle East & Africa Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 123 Middle East & Africa Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 124 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 125 Middle East & Africa Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 126 Middle East & Africa Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 127 Middle East & Africa Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 128 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 129 Middle East & Africa Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 130 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 131 Middle East & Africa Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 132 Middle East & Africa Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)